Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ImmuCell Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ICCC
Nasdaq
8731
https://immucell.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ImmuCell Corp
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
- Apr 9th, 2024 8:05 pm
ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 1:25 pm
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
- Feb 27th, 2024 9:05 pm
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
- Feb 16th, 2024 2:30 pm
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
- Jan 8th, 2024 9:05 pm
ImmuCell Corporation (NASDAQ:ICCC) Q3 2023 Earnings Call Transcript
- Nov 15th, 2023 7:04 pm
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
- Nov 13th, 2023 9:05 pm
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
- Nov 7th, 2023 5:15 pm
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
- Oct 5th, 2023 8:05 pm
ImmuCell Announces Submission of CMC Technical Section to the FDA
- Aug 29th, 2023 12:00 pm
Q2 2023 ImmuCell Corp Earnings Call
- Aug 12th, 2023 2:16 am
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023
- Aug 10th, 2023 8:05 pm
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023
- Aug 7th, 2023 4:00 pm
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023
- Jul 11th, 2023 8:05 pm
ImmuCell Announces Change in Timing of Anticipated FDA Submission
- Jun 28th, 2023 8:05 pm
ImmuCell Appoints Bryan K. Gathagan to Board of Directors
- Jun 21st, 2023 8:05 pm
ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility
- Jun 15th, 2023 8:05 pm
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
- May 16th, 2023 1:00 pm
There's No Escaping ImmuCell Corporation's (NASDAQ:ICCC) Muted Revenues
- May 15th, 2023 11:36 am
Q1 2023 ImmuCell Corp Earnings Call
- May 13th, 2023 1:46 am
Scroll